Characteristics of CVID patients with high, intermediate, and low pl.IL-7
. | . | . | . | . | . | . | Leukocytes, 106/mm3 . | . | . | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
. | Age, y . | Women, % . | Age at onset, y . | Splenomegaly, % . | Bronchiectasis, % . | Autoimmune phenomena, % . | CD4 . | CD8 . | CD19 . | ||
| High pl.IL-7 (> 10 pg/mL), n = 13 | 37 | 18 | 21 | 55 | 73 | 73 | 1190 | 1261 | 347 | ||
| Intermediate pl.IL-7 (6.5-10 pg/mL), n = 11 | 38 | 45 | 22 | 36 | 45 | 18 | 580 | 564 | 161 | ||
| Normal pl.IL-7 (< 6.4), n = 47 | 44 | 51 | 26 | 32 | 40 | 30 | 702 | 777 | 262 | ||
. | . | . | . | . | . | . | Leukocytes, 106/mm3 . | . | . | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
. | Age, y . | Women, % . | Age at onset, y . | Splenomegaly, % . | Bronchiectasis, % . | Autoimmune phenomena, % . | CD4 . | CD8 . | CD19 . | ||
| High pl.IL-7 (> 10 pg/mL), n = 13 | 37 | 18 | 21 | 55 | 73 | 73 | 1190 | 1261 | 347 | ||
| Intermediate pl.IL-7 (6.5-10 pg/mL), n = 11 | 38 | 45 | 22 | 36 | 45 | 18 | 580 | 564 | 161 | ||
| Normal pl.IL-7 (< 6.4), n = 47 | 44 | 51 | 26 | 32 | 40 | 30 | 702 | 777 | 262 | ||
Summarized data for CVID patients stratified according to plasma levels of IL-7.